These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29558894)

  • 41. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An assessment of differences in costs and health benefits of serology and NAT screening of donations for blood transfusion in different Western countries.
    Janssen MP; van Hulst M; Custer B;
    Vox Sang; 2017 Aug; 112(6):518-525. PubMed ID: 28639703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Economic evaluation and prediction of hepatitis B immunization strategy in Shenzhen, China].
    Sun PP; Zhang SX; Xia Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Jul; 52(7):743-747. PubMed ID: 29996303
    [No Abstract]   [Full Text] [Related]  

  • 44. Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimates.
    Baral R; Nonvignon J; Debellut F; Agyemang SA; Clark A; Pecenka C
    BMC Public Health; 2020 May; 20(1):619. PubMed ID: 32370763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The economic burden of dementia in low- and middle-income countries (LMICs): a systematic review.
    Mattap SM; Mohan D; McGrattan AM; Allotey P; Stephan BC; Reidpath DD; Siervo M; Robinson L; Chaiyakunapruk N
    BMJ Glob Health; 2022 Apr; 7(4):. PubMed ID: 35379735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of universal hepatitis B virus screening in patients beginning chemotherapy for solid tumors.
    Day FL; Karnon J; Rischin D
    J Clin Oncol; 2011 Aug; 29(24):3270-7. PubMed ID: 21788556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An economic assessment of pre-vaccination screening for hepatitis A and B.
    Jacobs RJ; Saab S; Meyerhoff AS; Koff RS
    Public Health Rep; 2003; 118(6):550-8. PubMed ID: 14563912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Economic Evaluations of Child Nutrition Interventions in Low- and Middle-Income Countries: Systematic Review and Quality Appraisal.
    Baek Y; Ademi Z; Paudel S; Fisher J; Tran T; Romero L; Owen A
    Adv Nutr; 2022 Feb; 13(1):282-317. PubMed ID: 34510178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessing cost-effectiveness of HPV vaccines with decision analytic models: what are the distinct challenges of low- and middle-income countries? A protocol for a systematic review.
    Ekwunife OI; Grote AG; Mosch C; O'Mahony JF; Lhachimi SK
    Syst Rev; 2015 May; 4():68. PubMed ID: 25963745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost effectiveness of screening immigrants for hepatitis B.
    Wong WW; Woo G; Jenny Heathcote E; Krahn M
    Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.
    Dan YY; Wai CT; Yeoh KG; Lim SG
    Liver Transpl; 2006 May; 12(5):736-46. PubMed ID: 16628682
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Limited hepatitis B immunoglobulin with potent nucleos(t)ide analogue is a cost-effective prophylaxis against hepatitis B virus after liver transplantation.
    Singer GA; Zielsdorf S; Fleetwood VA; Alvey N; Cohen E; Eswaran S; Shah N; Chan EY; Hertl M; Fayek SA
    Transplant Proc; 2015 Mar; 47(2):478-84. PubMed ID: 25769595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic Analysis of Children's Surgical Care in Low- and Middle-Income Countries: A Systematic Review and Analysis.
    Saxton AT; Poenaru D; Ozgediz D; Ameh EA; Farmer D; Smith ER; Rice HE
    PLoS One; 2016; 11(10):e0165480. PubMed ID: 27792792
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
    Shepherd J; Cooper K; Harris P; Picot J; Rose M
    Health Technol Assess; 2016 Apr; 20(34):1-222. PubMed ID: 27135404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Economic Costs of Type 2 Diabetes: A Global Systematic Review.
    Seuring T; Archangelidi O; Suhrcke M
    Pharmacoeconomics; 2015 Aug; 33(8):811-31. PubMed ID: 25787932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
    Goyal A; Murray JM
    Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.